Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
Often, we refer to companies developing coronavirus vaccines as rivals. We're all betting on which one will make it to market first or become top supplier. There is, of course, a leadership position up for grabs -- and not every company will win it.
But considering worldwide need for a vaccine, there is room for many players. As of Dec. 1, 11 coronavirus vaccine developers have moved their projects into phase 3 clinical trials. Of those 11, five are companies based in the U.S. or Europe. We need all five of these companies -- and likely their Chinese and Russian rivals -- to end the pandemic. Let's take a look at where things stand.
Source Fool.com
